Patents by Inventor Massimiliano Dagli Alberi

Massimiliano Dagli Alberi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER
    Publication number: 20230277451
    Abstract: The present invention generally relates to pharmaceutical composition comprising a LABA agent, optionally in combination with other active ingredients, a mixture of at least two inorganic acids, a propellant and a co-solvent. The invention also provides a pharmaceutical composition for the treatment of respiratory diseases, such as asthma and COPD.
    Type: Application
    Filed: October 8, 2021
    Publication date: September 7, 2023
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Enrico ZAMBELLI, Sauro BONELLI, Diego COPELLI, Massimiliano DAGLI ALBERI, Francesca USBERTI
  • STAINLESS STEEL CAN FOR PRESSURISED METERED DOSE INHALERS
    Publication number: 20220395454
    Abstract: The invention generally refers to a stainless steel can for use in a metered dose inhaler device, containing an aerosol formulation, comprising glycopyrronium bromide and formoterol, or a salt or a solvate thereof, optionally in combination with one or more additional active ingredient, endowed with a high stability.
    Type: Application
    Filed: December 2, 2019
    Publication date: December 15, 2022
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Enrico ZAMBELLI, Sauro BONELLI, Diego COPELLI, Massimiliano DAGLI ALBERI, Francesca USBERTI
  • Stable pressurized aerosol solution composition of glycopyrronium bromide and formoterol combination
    Patent number: 10617669
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: April 14, 2020
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Sauro Bonelli, Diego Copelli, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
  • Stable pressurized aerosol solution composition of glycopyrronium bromide and formoterol combination
    Patent number: 10617638
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof or a solvate of said salt, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in a can internally coated by a resin comprising a fluorinated ethylene propylene (FEP) polymer.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: April 14, 2020
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Sauro Bonelli, Diego Copelli, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
  • Stable pressurized aerosol solution composition of glycopyrronium bromide and formoterol combination
    Patent number: 10596113
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof or a solvate of said salt, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in a can internally coated by a resin comprising a fluorinated ethylene propylene (FEP) polymer.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: March 24, 2020
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro Bonelli, Diego Copelli, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
  • Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
    Patent number: 10596149
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: March 24, 2020
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro Bonelli, Diego Copelli, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
  • STABLE PRESSURISED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION
    Publication number: 20170095444
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.
    Type: Application
    Filed: December 15, 2016
    Publication date: April 6, 2017
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro BONELLI, Diego COPELLI, Massimiliano Dagli ALBERI, Francesca USBERTI, Enrico ZAMBELLI
  • STABLE PRESSURIZED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION
    Publication number: 20160303044
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.
    Type: Application
    Filed: June 29, 2016
    Publication date: October 20, 2016
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Sauro BONELLI, Diego Copelli, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
  • STABLE PRESSURIZED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION
    Publication number: 20160303045
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof or a solvate of said salt, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in a can internally coated by a resin comprising a fluorinated ethylene propylene (FEP) polymer.
    Type: Application
    Filed: June 29, 2016
    Publication date: October 20, 2016
    Applicant: CHIESI FARMACEUTICI S.P.A
    Inventors: Sauro BONELLI, Diego Copelli, Massimiliano Dagli Alberi, Francesca Usberti, Enrico Zambelli
  • USE OF MAGNESIUM STEARATE IN DRY POWDER FORMULATIONS FOR INHALATION
    Publication number: 20150320691
    Abstract: Addition of magnesium stearate to a powder formulation for inhalation comprising carrier particles and an active ingredient bearing a group susceptible to hydrolysis is useful for inhibiting or reducing the chemical degradation of the active ingredient.
    Type: Application
    Filed: July 17, 2015
    Publication date: November 12, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela COCCONI, Massimiliano Dagli ALBERI, Andrea BUSCA, Francesca SCHIARETTI
  • STABLE PRESSURISED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION
    Publication number: 20150182450
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof or a solvate of said salt, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in a can internally coated by a resin comprising a fluorinated ethylene propylene (FEP) polymer.
    Type: Application
    Filed: December 30, 2014
    Publication date: July 2, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro BONELLI, Diego COPELLI, Massimiliano Dagli ALBERI, Francesca USBERTI, Enrico ZAMBELLI
  • STABLE PRESSURISED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION
    Publication number: 20150182459
    Abstract: Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.
    Type: Application
    Filed: December 30, 2014
    Publication date: July 2, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Sauro BONELLI, Diego COPELLI, Massimiliano Dagli ALBERI, Francesca USBERTI, Enrico ZAMBELLI
  • USE OF MAGNESIUM STEARATE IN DRY POWDER FORMULATIONS FOR INHALATION
    Publication number: 20120082727
    Abstract: Addition of magnesium stearate to a powder formulation for inhalation comprising carrier particles and an active ingredient bearing a group susceptible to hydrolysis is useful for inhibiting or reducing the chemical degradation of the active ingredient.
    Type: Application
    Filed: September 22, 2011
    Publication date: April 5, 2012
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela Cocconi, Massimiliano Dagli Alberi, Andrea Busca, Francesca Schiaretti
  • PHARMACEUTICAL FORMULATION COMPRISING AN ANTICHOLINERGIC DRUG
    Publication number: 20090180969
    Abstract: Pharmaceutical formulations suitable to be administered by pressurised metered dose inhalers (pMDIs) comprising a salt of 3-[[[(3-fluorophenyl)[(3,4,5-trifluoro phenyl)methyl]amino]carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane are effective for the prevention and/or treatment of an obstructive airways disease.
    Type: Application
    Filed: December 24, 2008
    Publication date: July 16, 2009
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Sauro BONELLI, Massimiliano Dagli Alberi